As 2024 comes to a close, we take a moment to reflect on some of our milestones from this year. [read more] | |
|
It is with great sadness that we mourn our cherished friend and colleague Felix Feng, MD. | |
|
Held last month in San Francisco, the RISE UP Breast Cancer Symposium convened over 300 researchers and physicians across multiple disciplines to discuss strategies to reduce mortality against the disease. | |
Mitch Berger, MD received the Society of NeuroOncology (SNO) Lifetime Achievement Award.
Laura J. Zitella, NP, MSN was awarded the America's Top NP Award for Oncology.
Erin Van Blarigan, ScD was awarded an extension of her R37 award, "MERIT Extension of Optimization of a remote intervention to improve nutrition and physical activity in cancer survivors."
Matthew Springer, PhD received a grant from the National Heart, Lung and Blood Institute for a project, "Cardiovascular effects of inhalable tobacco product dual use."
Maggie Colton Cove, a PhD candidate, was named among the 2024 class of
Representation in Science (RISE) Scholar award recipients by the Parker
Institute for Cancer Immunotherapy.
Chris Cadwell, Yaron Gesthalter, MD, and the Benioff Children's Hospitals Cross Bay Neuro-Oncology Team received 2024 Q3 PRIDE Experience Awards.
| |
Yang Y, Badura ML, O'Leary PC, Delavan HM, Robinson TM, Egusa EA, Zhong X, Swinderman JT, Li H, Zhang M, Kim M, Ashworth A, Feng FY, Chou J, Yang L. Transcription and DNA replication collisions lead to large tandem duplications and expose targetable therapeutic vulnerabilities in cancer. Nat Cancer. 2024 Nov 18.
Callander JK, Johnson DE, Grandis JR. Social capital as a catalyst for gender inequality: A scoping review of networking disparities in academic medicine. Cancer. Published online Nov 29, 2024.
Vasudevan HN, Lazar AA, Reyes K, Rong DA, Arevalo S, Federman S, Chan JW, Chiu CY, Miller S, Yom SS. Comparison of Plasma Metagenomic Next-generation Sequencing and PCR Methods for Epstein-Barr Virus Viral Load Monitoring in Nasopharyngeal Carcinoma. Anticancer Res. 2024 Dec;44(12):5445-5453.
Rugo HS, Campbell M, Yau C, Jo Chien A, Wallace AM, Isaacs C, Boughey JC, Han HS, Buxton M, Clennell JL, Asare SM, Steeg K, Wilson A, Singhrao R, Matthews JB, Perlmutter J, Fraser Symmans W, Hylton NM, DeMichele AM, Yee D, Van't Veer LJ, Berry DA, Esserman LJ. Pexidartinib and standard neoadjuvant therapy in the adaptively randomized I-SPY2 trial for early breast cancer. Breast Cancer Res Treat. 2024 Dec 3.
| |
Cancer Community Connect Newsletter | |
View the December issue of Cancer Community Connect, a newsletter for cancer center trainees, staff, and faculty that focuses on opportunities in career development, mentorship, DEIA, and community engagement! | |
|
Dec 13: Cancer Center Friday Seminar in Basic & Translational Research
M. Celeste Simon, PhD (University of Pennsylvania) will present, "Can Cancer Metabolism be Exploited for Therapeutic Gain?"
Dec 17: ASCO Oncology Summer Internship Info Session
Join us for an informational session on the ASCO Oncology Summer Internship program for underrepresented in medicine students.
Jan 8: Bay Area Breast Cancer Forum
Drs. Hope Rugo, Michelle Melisko, Jo Chien, Laura Huppert, and Hemali Batra-Sharma will discuss updates from the 2024 San Antonio Breast Cancer Symposium.
Jan 14: Zena Werb Memorial Lecture in Cancer Biology
Nobel Laureate Carolyn Bertozzi, PhD, will present, "Targeting the Glycocalyx for Cancer Immune Therapy." Reception to follow.
Jan 17: HDFCCC Sarcoma Research Hub Symposium
This half-day symposium will include talks by Drs. Ross Okimoto, Harish Vasudevan, Matthew Bucknor, Elysia Alvarez (UC Davis), and more.
|
| | | |